Familial Primary Pulmonary Hypertension: all 352 studies
Page 3 of 4. Open to participants first (35), then studies with results posted, then the rest; newest registration first within each.
- A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1)TerminatedNCT03924154Phase 2
- miRNA and Myokines in Patients With PAHWithdrawnNCT03905083Not applicable
- A Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic SclerosisCompletedNCT03889509
- Hemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of TreprostinilTerminatedNCT03884465Phase 2
- Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the LungsCompletedNCT03863990
- Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAHStatus unknownNCT03841344Not applicable
- Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH)Status unknownNCT03819777
- Prevalence of the Hyperventilation Syndrome in Pulmonary Arterial HypertensionStatus unknownNCT03810443Not applicable
- Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion of Study PB1046-PT-CL-0004TerminatedNCT03795428Phase 2
- Study to Evaluate Efficacy and Safety of JTT-251 in Participants With Pulmonary Arterial HypertensionWithdrawnNCT03789643Phase 2
- Olaparib for PAH: a Multicenter Clinical TrialTerminatedNCT03782818Phase 1/2
- PET/MRI in PAH PatientsCompletedNCT03688698
- Oxygen Treatment and Pulmonary Arterial HypertensionStatus unknownNCT03683082Not applicable
- Apabetalone for Pulmonary Arterial Hypertension: a Pilot StudyCompletedNCT03655704Early Phase 1
- A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH PatientsCompletedNCT03626688Phase 3
- Neuromuscular Electrical Stimulation in Pulmonary Arterial HypertensionCompletedNCT03612115Not applicable
- Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled NitricWithdrawnNCT03602781Phase 3
- Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAHTerminatedNCT03556020Phase 2
- Combined Use of Radiofrequency-ablation and Balloon-septostomy in the Creation of a Stable Inter-atrial CommunicationStatus unknownNCT03554330Not applicable
- Effects of Different Types of Physical Training in Patients With Pulmonary Arterial Hypertension.Status unknownNCT03476629Not applicable
- A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies.CompletedNCT03422328Phase 3
- Effect of Morphine on Dyspnea and 6-Minute Walk Distance in Pulmonary Arterial HypertensionStatus unknownNCT03401476Phase 2
- A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAHCompletedNCT03315507Phase 1
- Olaparib for PAH: a Pilot StudyTerminatedNCT03251872Early Phase 1
- Goal Oriented Strategy to Preserve Ejection Fraction TrialStatus unknownNCT03236818Phase 4
- The PAH Disability and Bothersomeness QuestionnaireStatus unknownNCT03235401
- Determinants of Right Heart Remodeling in Patients With CTEPH or PAHStatus unknownNCT03205085Not applicable
- Angiogenic Imaging in Pulmonary Arterial HypertensionCompletedNCT03166306Phase 1/2
- ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApyCompletedNCT03145298Phase 1
- Repeatability of OCT and IV-US in Pulmonary Arterial HypertensionCompletedNCT03105934Not applicable
- Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial HypertensionCompletedNCT03057028Phase 1
- To Compare the Efficacy of Combination Therapy vs Monotherapy for Pulmonary Arterial Hypertension in Systemic SclerosisStatus unknownNCT03053739Phase 4
- Impact of Rehabilitation Program on PAH Patients Treated With Macitentan.Status unknownNCT03045666Not applicable
- Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAHWithdrawnNCT03016468Phase 2
- Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial HypertensionWithdrawnNCT02999906Phase 3
- Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA)TerminatedNCT02968901Phase 4
- The Effect of Adding Exercise Training to Optimal Therapy in PAHCompletedNCT02961023Not applicable
- Physiopathology of Pulmonary Arterial Hypertension: Mechanistic StudiesStatus unknownNCT02959723
- FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With AmbrisentanWithdrawnNCT02958358Not applicable
- [18F]FES PET/CT in PAHTerminatedNCT02899533
- Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial HypertensionWithdrawnNCT02893995Phase 4
- LenusPro Pump in PAH Treated With TreprostinilStatus unknownNCT02889315
- Contribution of Echocardiography to Prognostic Evaluation of Pulmonary Arterial HypertensionCompletedNCT02885155
- An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial HypertensionWithdrawnNCT02882126Phase 4
- The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation PatientsCompletedNCT02859194Not applicable
- MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial HypertensionCompletedNCT02858791
- Acute Effects of Benzbromaron on the Pulmonary CirculationCompletedNCT02790450Phase 2
- Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial HypertensionWithdrawnNCT02782052Phase 3
- Right Ventricular Metabolism in Pulmonary Arterial HypertensionCompletedNCT02763735
- A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial HypertensionCompletedNCT02676947Phase 2
- Cardiac Function and Exercise Capacity in Pulmonary Arterial HypertensionCompletedNCT02579954Not applicable
- Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term OutcomeCompletedNCT02565030
- Pulmonary Artery Denervation for Treatment of Pulmonary Arterial HypertensionTerminatedNCT02525926Not applicable
- Study to Assess Acute Vasodilation Response of Inhaled Nitric OxideWithdrawnNCT02436512Phase 3
- Ventricular Reversed Remodeling After LTX in PAH PatientsCompletedNCT02391441
- Aerobic Exercise Training in Pulmonary Arterial HypertensionCompletedNCT02371733Not applicable
- Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension (PAH)CompletedNCT02318186
- Correlation of LONGterm Wrist ACTigraphy Recorded Physical Performance & 6-minute Walk Distance in Patients With Pulmonary Arterial HypertensionWithdrawnNCT02309463
- Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAHCompletedNCT02304198Phase 2/3
- Observatory of Pulmonary Arterial Hypertension of Congenital Heart DiseaseCompletedNCT02260362
- Safety of Terbogrel in Patients With Primary Pulmonary HypertensionTerminatedNCT02223494Phase 2
- Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary HypertensionCompletedNCT02223481Phase 2
- Imaging Control Study, 3D Echo, MR and RHC.Status unknownNCT02198456
- Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAHCompletedNCT02112487Phase 3
- Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial HypertensionWithdrawnNCT02108743Phase 2
- Comparative PK PD Study in PAH Patients (Fox vs. I-Neb)CompletedNCT02032836Phase 1/2
- Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial HypertensionStatus unknownNCT02023450Early Phase 1
- BEET PAH: a Study to Assess the Effects of Beetroot Juice in Patients With Pulmonary Arterial HypertensionCompletedNCT02000856Not applicable
- Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)CompletedNCT01966302Phase 2
- Novel Screening Strategies for Scleroderma PAHCompletedNCT01959815
- Hydroxyurea in Pulmonary Arterial HypertensionWithdrawnNCT01950585Early Phase 1
- National Cohort Study of Idiopathic and Heritable Pulmonary Arterial HypertensionStatus unknownNCT01907295
- Resynchronisation Therapy of Right Ventricle in Pulmonary Arterial HypertensionStatus unknownNCT01905189Not applicable
- (-)-Epicatechin and Pulmonary Arterial HypertensionWithdrawnNCT01880866Phase 1
- Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial HypertensionTerminatedNCT01847716
- Obstructive Sleep Apnea (OSA) in Pulmonary Arterial Hypertension (PAH)TerminatedNCT01835080
- Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasEStatus unknownNCT01827059Phase 2
- Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)TerminatedNCT01795950Phase 1
- Patient Reported Outcomes in Pulmonary Arterial HypertensionWithdrawnNCT01792622
- Observational Description of Compliance for the Daily Ventavis Use Via the Insight Program in Class III Pulmonary Arterial Hypertension PatientsCompletedNCT01781052
- A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial HypertensionCompletedNCT01757808Phase 1
- Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05TerminatedNCT01725269Phase 2
- A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)TerminatedNCT01725256Phase 2
- Beta Blockers for Treatment of Pulmonary Arterial Hypertension in ChildrenWithdrawnNCT01723371Phase 1/2
- Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension PatientsStatus unknownNCT01712997Phase 3
- Exercise Capacity and Quality of Life in Patients With PPH Receiving Short Term Oral L-Citrulline MalateStatus unknownNCT01683981Early Phase 1
- Efficacy Study of Cardizem in Pulmonary Arterial HypertensionWithdrawnNCT01645826Not applicable
- Proof of Concept Study of IMMUNOadsorption Therapy in Patients With Idiopathic Pulmonary Arterial HypertensionCompletedNCT01613287Not applicable
- Screening of Pulmonary Arterial Hypertension in BMPR2 Mutation CarriersCompletedNCT01600898
- The Study of Apelin-APJ System on Pulmonary Hypertension Patients and Healthy SubjectsCompletedNCT01590108Phase 1
- Vascular Subphenotypes of Lung Disease in HIV & COPDCompletedNCT01581086
- Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial HypertensionCompletedNCT01572077Not applicable
- Inhaled Treprostinil for PAH: Open-label ExtensionWithdrawnNCT01557660Phase 3
- Safety and Efficacy of Inhaled Treprostinil in Patients With PAHWithdrawnNCT01557647Phase 3
- Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)CompletedNCT01553721Phase 2
- Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary HypertensionCompletedNCT01548950Not applicable
- Peripheral Muscle Microcirculation and Exercise-induced Blood Flow Distribution in Pulmonary Arterial HypertensionCompletedNCT01520493Not applicable
- Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral BosentanWithdrawnNCT01508780Phase 4
- Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion MatchingTerminatedNCT01494896
- Evaluation of Pulmonary Perfusion Heterogeneity and Compliance in Patients With Pulmonary Hypertension Using Positron Emission Tomography ImagingCompletedNCT01461343Not applicable